B
Evidence Grade B
Graded
accuracy verified by the review judge
Safe to Cite
Recent
62
62 -- pipeline perception score for Sacituzumab tirumotecan (Merck) (2025-03)
Sacituzumab tirumotecan (Merck) achieved a pipeline perception score of 62 based on a survey of oncologists.
Attribution:
View source
Lighthouse Research Team
Last verified:
·
How we verify data →
Source verified
Evidence graded
Value
62
Unit
Score
Data Vintage
2025-03
Entity
Sample Size
101
Evidence Quality
B
Strong, reliable evidence
Sourced from a well-regarded research firm or industry leader with transparent methodology and a reasonably large sample.
Single source - not yet corroborated
Score breakdown
Extraction
95
Source Trust
60
Citation Chain
20
Independence
30
Methodology
45
Freshness
95
Source
ZoomRx
Primary
Tier A
https://blog.zoomrx.com/brand-builder/asco-2025-preview-oncology-pipeline-dynamics-and-healthcare-pr… ↗
Source Article
ASCO 2025 Preview: Oncology Pipeline Dynamics and Healthcare Provider Priorities
ADCs & Bispecifics Lead Oncologist Excitement for Emerging Cancer Therapies
Healthcare Provider Sentiment Toward Emerging Cancer Therapeutics
As the oncology community prepares for American Society of Clinical Oncology's annual meeting in 2025, new research from ZoomRx reveals which therapeutic appr…
Original Research
ZoomRx
· Original study ↗
Methodology
ZoomRx combined awareness and excitement metrics perception score among 101 oncologists
Methodology documented
Segmentation
Industrymarketing
Cite this stat
Plain Text
Sacituzumab tirumotecan (Merck): 62 pipeline perception score. Source: ZoomRx (2025-03). Via Lighthouse Intelligence -- https://lighthousedata.io/data/sacituzumab-tirumotecan-perception-score-2025
HTML Embed
<blockquote cite="https://lighthousedata.io/data/sacituzumab-tirumotecan-perception-score-2025" style="border-left:3px solid #2563eb;padding:12px 16px;margin:16px 0;font-family:system-ui,sans-serif;background:#f0f4ff;"><strong>62</strong> -- pipeline perception score for Sacituzumab tirumotecan (Merck)<br><small>Source: ZoomRx (2025-03) · <a href="https://lighthousedata.io/data/sacituzumab-tirumotecan-perception-score-2025" target="_blank" rel="noopener">Lighthouse Intelligence</a></small></blockquote>
Share
Related Statistics
Use this data in your work
Copy the citation, embed the widget, or explore thousands more verified marketing statistics -- all free.